These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1306601)

  • 21. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.
    Sato S; Hirakata M; Kuwana M; Suwa A; Inada S; Mimori T; Nishikawa T; Oddis CV; Ikeda Y
    Arthritis Rheum; 2005 May; 52(5):1571-6. PubMed ID: 15880816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced anticentromere antibody?
    Haberhauer G; Bröll H
    Z Rheumatol; 1989; 48(2):99-100. PubMed ID: 2786663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis.
    Komura K; Fujimoto M; Matsushita T; Kaji K; Kondo M; Hirano T; Orito H; Horikawa M; Hamaguchi Y; Hasegawa M; Takehara K; Sato S
    J Dermatol Sci; 2005 Dec; 40(3):215-7. PubMed ID: 16289693
    [No Abstract]   [Full Text] [Related]  

  • 26. Humoral immunity in polymyositis and dermatomyositis.
    Targoff IN; Reichlin M
    Mt Sinai J Med; 1988 Nov; 55(6):487-93. PubMed ID: 3068537
    [No Abstract]   [Full Text] [Related]  

  • 27. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
    Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
    Marcus SN; Chadwick D; Walker RJ
    Gastroenterology; 1984 Jan; 86(1):166-8. PubMed ID: 6689658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis.
    Hassan AB; Fathi M; Dastmalchi M; Lundberg IE; Padyukov L
    J Autoimmun; 2006 Aug; 27(1):62-8. PubMed ID: 16895750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis.
    Roux S; Seelig HP; Meyer O
    J Rheumatol; 1998 Feb; 25(2):395-6. PubMed ID: 9489847
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immune diagnosis of collagen diseases].
    Sönnichsen N
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):519-21. PubMed ID: 6975540
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoantibodies in juvenile dermatomyositis.
    Martínez-Cordero E; Martínez-Miranda E; Aguilar León DE
    Clin Rheumatol; 1993 Sep; 12(3):426-8. PubMed ID: 8258249
    [No Abstract]   [Full Text] [Related]  

  • 36. [Extracapillary glomerulonephritis secondary to D-penicillamine. Apropos of 1 case and review of the literature].
    Marchand-Courville S; Dhib M; Fillastre JP; Godin M
    Nephrologie; 1998; 19(1):25-32. PubMed ID: 9551449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On various characteristics of dermatopolymyositis in children].
    NALBAT AS; CHUGUNOVA TI
    Sov Med; 1960 Apr; 24():143-7. PubMed ID: 14425934
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of dermatopolymyositis of favourable course after total body irradiation].
    Aimard L; Sainty JM; Gastaut JL; Durand-Gasselin J; Motta-Veyssieres J; Pouget J
    Presse Med; 1987 Sep; 16(29):1436. PubMed ID: 2958808
    [No Abstract]   [Full Text] [Related]  

  • 40. Penicillamine-induced dermatomyositis.
    Wojnarowska FT
    J R Soc Med; 1981 Jun; 74(6):469. PubMed ID: 20894358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.